Cardiopulmonary OxygenatorMarket in North America report 2030 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Cardiopulmonary Oxygenator Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Cardiopulmonary Oxygenator Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in heart and lung diseases
5.1.2 Rising number of cardiac surgeries
5.1.3 Advancements in oxygenator technology

5.2 Market Opportunities

5.2.1 Rising need for oxygenators in cardiac surgeries
5.2.2 Increasing adoption of heart-lung machines in surgeries
5.2.3 Technological advancements in cardiopulmonary oxygenator systems

5.3 Future Trends

5.3.1 Technological advancements in heart-lung machine systems
5.3.2 Rise in minimally invasive cardiac surgeries
5.3.3 Increasing global demand for cardiac surgeries and treatments

5.4 Impact of Drivers and Restraints

6. North America Cardiopulmonary Oxygenator Market Regional Analysis

6.1 North America Cardiopulmonary Oxygenator Market Overview

6.2 North America Cardiopulmonary Oxygenator Market Revenue 2020-2028 (US$ Million)

6.3 North America Cardiopulmonary Oxygenator Market Forecast Analysis

7. North America Cardiopulmonary Oxygenator Market Analysis – by Product

7.1 Bubble Oxygenator and Membrane Oxygenator

7.1.1 Overview
7.1.2 Bubble Oxygenator and Membrane Oxygenator: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cardiopulmonary Oxygenator Market Analysis – by Application

8.1 Cardiac and Respiratory

8.1.1 Overview
8.1.2 Cardiac and Respiratory: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Cardiopulmonary Oxygenator Market Analysis – by Type

9.1 Disposable Cardiopulmonary Oxygenator and Reusable Cardiopulmonary Oxygenator

9.1.1 Overview
9.1.2 Cardiac and Respiratory: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Cardiopulmonary Oxygenator Market – North America Analysis

10.1 North America

10.1.1 North America Cardiopulmonary Oxygenator Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 North America Cardiopulmonary Oxygenator Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Product
10.1.1.1.2 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Application
10.1.1.1.3 US: North America Cardiopulmonary Oxygenator Market Breakdown, by Type

10.1.1.2 Canada: North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Product
10.1.1.2.2 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Application
10.1.1.2.3 Canada: North America Cardiopulmonary Oxygenator Market Breakdown, by Type

10.1.1.3 Mexico : North America Cardiopulmonary Oxygenator Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Product
10.1.1.3.2 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Cardiopulmonary Oxygenator Market Breakdown, by Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Cardiopulmonary Oxygenator Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Getinge AB

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 LivaNova Plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Medtronic Plc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Terumo Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Nipro Medical Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Microport Scientific Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Braile Biomedica Industry, Commerce and Representation Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Chalice Medical Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Fresenius Medical Care AG & Co KGaA

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights